Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This clinical study to evaluate sonobiopsy is significant because sonobiopsy will fundamentally enhance the clinician's insight into the molecular features of an intracranial lesion to tailor treatment approaches and optimize outcomes. In addition to the standard diagnostics of anatomic imaging and surgical histology, sonobiopsy has the potential to become the third pillar for brain tumor management by radically advancing the ability to easily and regularly acquire tumor genetic and molecular signatures. This enhanced capability will have a dramatic impact on patient survival and quality of life.
Sponsor: Washington University School of Medicine
You may qualify if…
- ✓ Must be newly diagnosed with a lesion in the brain with imaging characteristics consistent with glioblastoma multiforme. Scan must have occurred no more than 28 days prior to enrollment.
- ✓ Lesion must be \> 3 cm in maximal dimension on MRI.
- ✓ Lesion must be in the supratentorial space within 5 cm of the cortical surface.
- ✓ Lesion must be gadolinium enhancing.
- ✓ Low grade tumors and metastatic tumors
- ✓ Recurrent brain tumors and/or radiation necrosis
- ✓ Must be planning to undergo surgical resection of the tumor.
- ✓ Must be at least 18 years old.
You may not qualify if…
- ✕ Contraindication to MRI.
- ✕ Previous cranial surgery.
- ✕ Previous history of cancer and/or cancer treatments.
- ✕ Coagulopathy within 14 days of enrollment defined as PT/PTT outside of normal parameters and platelets \< 100,000/mcL.
- ✕ Physical skull defect of any kind.
- ✕ Ferrous material in the scalp or skull.
- ✕ Scalp or skin disease that limits contact with the ultrasound probe.
- ✕ Enrolled in another clinical trial where intervention is administered prior to surgery.
Where it's recruiting
St Louis
Source: ClinicalTrials.gov · NCT05281731 · last updated 2026-05-14